Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 5/2018

01-05-2018 | UNM Clinical Case Conferences

Latent Hepatitis Virus Reactivation Due to Drug Reaction: DRESSed to Kill?

Authors: David Alexanian, Aleksandr Birg, Nicholas Volpicelli, Joseph Glass, Denis McCarthy

Published in: Digestive Diseases and Sciences | Issue 5/2018

Login to get access

Excerpt

A 48-year old man was admitted to hospital with the new onset of a rash and abnormal liver function tests. The patient’s medical history included well-controlled diabetes mellitus type 2, gout, hyperlipidemia, stage 3 chronic kidney disease, and chronic low-back pain that had started 6 months prior to hospitalization; he had no known allergies. He had no relevant family or occupational history and lived with his wife. He denied smoking or illicit drug use and drank alcohol only in moderation. …
Literature
1.
Crado PR, Criado RFJ, Avancini JdM, Santi CG. Drug reaction with eosinophilia and systemic symptoms (DRESS)/Drug-induced Hypersensitivity Syndrome (DIHS): a review of current concepts. Ann Bras Dermatol. 2012;87:435–449.CrossRef
2.
Whitley RJ. In: Baron S, eds. Medical Microbiology. 4th ed. Galveston, TX: University of Texas Medical Branch at Galveston; Chapter 68; 1996.
3.
Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol. 2007;156:1083–1084.CrossRefPubMed
4.
International Committee on Taxonomy of Viruses. ICTV Master Species List 2011.
5.
Johnson S, Mathews S, Hudnall SD. Human herpesvirus 6 lymphadenitis in drug rash with eosinophilia and systemic symptoms syndrome: a lymphoma mimic. Histopathology. 2017;70:1166–1170.CrossRefPubMed
6.
Ferrero NA, Pearson KC, Zedek DC, Morrell DS. Case report of drug rash with eosinophilia and systemic symptoms demonstrating human herpesvirus-6 reactivation. Pediatr Dermatol. 2013;30:608–613.CrossRefPubMed
7.
Isaacson E, Glaser CA, Forghani B, Amad Z, et al. Evidence of human herpesvirus-6 infection in 4 immunocompetent patients with encephalitis. Clin Infect Dis. 2005;40:890–893.CrossRefPubMed
8.
Challoner PB, Smith KT, Parker JD, MacLeod DL, et al. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci USA. 1995;92:7440–7444.CrossRefPubMedPubMedCentral
9.
Alvarez-Lafuente R, De las Heras V, BartoloméM Picazo JJ, Arroy R. Relapsing-remitting multiple sclerosis and human herpesvirus 6 active infection. Arch Neurol. 2004;61:1523–1527.CrossRefPubMed
10.
Härmä M, Höckerstedt K, Lautenschlager I. Human herpesvirus-6 and acute liver failure. Transplantation. 2003;76:536–539.CrossRefPubMed
11.
Charnot-Katsikas A, Baewer D, Cook L, David MZ. Fulminant hepatic failure attributed to infection with human herpesvirus 6 (HHV-6) in an immunocompetent woman: a case report and review of the literature. J Clin Virol. 2016;75:27–32.CrossRefPubMed
12.
13.
14.
15.
Blumberg BM, Mock DJ, Powers JM, Ito M, et al. The HHV6 paradox: ubiquitous commensal or insidious pathogen? A two-step in situ PCR approach. J Clin Virol. 2000;16:159–176.CrossRefPubMed
16.
Fotheringham J, Akhyani N, Vortmeyer A, Donati D, et al. Detection of active human herpesvirus-6 infection in the brain: correlation with polymerase chain reaction detection in cerebrospinal fluid. Infect Dis. 2007;195:450–454.CrossRef
17.
Flamand L, Gravel A, Boutolleau D, Alvarez-Lafuente R, et al. Multicenter comparison of PCR assays for detection of human herpesvirus 6 DNA in serum. J Clin Microbiol. 2008;46:2700–2706.CrossRefPubMedPubMedCentral
18.
19.
Asthana AK, Lubel JS. Reactivation of latent viruses after treatment with biological therapies. Virus Adapt Treat. 2014;6:1–10.
20.
Lopez-Serrano P, de la Fuente-Briongos E, Carrera- Alonso E, Perez-Calle JL, et al. Hepatitis B and immunosuppressive therapies for chronic inflammatory diseases: when and how to apply prophylaxis, with a special focus on corticosteroid therapy. World J Hepatol. 2015;7:539–547.CrossRefPubMedPubMedCentral
Metadata
Title
Latent Hepatitis Virus Reactivation Due to Drug Reaction: DRESSed to Kill?
Authors
David Alexanian
Aleksandr Birg
Nicholas Volpicelli
Joseph Glass
Denis McCarthy
Publication date
01-05-2018
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 5/2018
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5028-1

Other articles of this Issue 5/2018

Digestive Diseases and Sciences 5/2018 Go to the issue

Original Article

Adherence to a Low FODMAP Diet in Relation to Symptoms of Irritable Bowel Syndrome in Iranian Adults

Correspondence

Isolated Terminal Ileitis: When Is It Not Crohn’s Disease?

Editorial

Epidemiology of Upper Gastrointestinal Hemorrhage in the USA: Is the Bleeding Slowing Down?

Original Article

Determinants and Outcomes of Hospice Utilization Among Patients with Advance-Staged Hepatocellular Carcinoma in a Veteran Affairs Population

Original Article

Adenoma Detection Rate in Asymptomatic Patients with Positive Fecal Immunochemical Tests

Original Article

Genetic and Structural Analysis of a SKIV2L Mutation Causing Tricho-hepato-enteric Syndrome
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits